BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11377694)

  • 1. A new approach for the synthesis of isonitrile carborane derivatives. Ligands for metal based boron neutron capture therapy (BNCT) and boron neutron capture synovectomy (BNCS) agents.
    Valliant JF; Schaffer P
    J Inorg Biochem; 2001 May; 85(1):43-51. PubMed ID: 11377694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, NMR, and X-ray crystallographic analysis of C-hydrazino-C-carboxycarboranes: versatile ligands for the preparation of BNCT and BNCS agents and (99m)Tc radiopharmaceuticals.
    Valliant JF; Sogbein OO; Morel P; Schaffer P; Guenther KJ; Bain AD
    Inorg Chem; 2002 May; 41(10):2731-7. PubMed ID: 12005497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boron neutron capture synovectomy (BNCS) as a potential therapy for rheumatoid arthritis: radiobiological studies at RA-1 Nuclear Reactor in a model of antigen-induced arthritis in rabbits.
    Trivillin VA; Bruno LJ; Gatti DA; Stur M; Garabalino MA; Hughes AM; Castillo J; Pozzi EC; Wentzeis L; Scolari H; Schwint AE; Feldman S
    Radiat Environ Biophys; 2016 Nov; 55(4):467-475. PubMed ID: 27568399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, Molecular Docking, and In Vitro Boron Neutron Capture Therapy Assay of Carboranyl Sinomenine.
    Cai J; Hosmane NS; Takagaki M; Zhu Y
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33066470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An investigation of the feasibility of gadolinium for neutron capture synovectomy.
    Gierga DP; Yanch JC; Shefer RE
    Med Phys; 2000 Jul; 27(7):1685-92. PubMed ID: 10947274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and construction of a neutron beam line for accelerator-based boron neutron capture synovectomy.
    Gierga DP; Yanch JC; Shefer RE
    Med Phys; 2000 Jan; 27(1):203-14. PubMed ID: 10659758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carborane derivatives loaded into liposomes as efficient delivery systems for boron neutron capture therapy.
    Altieri S; Balzi M; Bortolussi S; Bruschi P; Ciani L; Clerici AM; Faraoni P; Ferrari C; Gadan MA; Panza L; Pietrangeli D; Ricciardi G; Ristori S
    J Med Chem; 2009 Dec; 52(23):7829-35. PubMed ID: 19954249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular delivery and passive tumor targeting of a self-assembled nanogel containing carborane clusters for boron neutron capture therapy.
    Kawasaki R; Sasaki Y; Akiyoshi K
    Biochem Biophys Res Commun; 2017 Jan; 483(1):147-152. PubMed ID: 28039054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vivo Application of Carboranes for Boron Neutron Capture Therapy (BNCT): Structure, Formulation and Analytical Methods for Detection.
    Marforio TD; Carboni A; Calvaresi M
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of boron containing monosaccharides by the hydroboration of d-glucal for use in boron neutron capture therapy (BNCT).
    Itoh T; Tamura K; Ueda H; Tanaka T; Sato K; Kuroda R; Aoki S
    Bioorg Med Chem; 2018 Dec; 26(22):5922-5933. PubMed ID: 30420329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposome formulations of o-carborane for the boron neutron capture therapy of cancer.
    Olusanya TOB; Calabrese G; Fatouros DG; Tsibouklis J; Smith JR
    Biophys Chem; 2019 Apr; 247():25-33. PubMed ID: 30797076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A stable meta-carborane enables the generation of boron-rich peptide agonists targeting the ghrelin receptor.
    Worm DJ; Els-Heindl S; Kellert M; Kuhnert R; Saretz S; Koebberling J; Riedl B; Hey-Hawkins E; Beck-Sickinger AG
    J Pept Sci; 2018 Oct; 24(10):e3119. PubMed ID: 30168238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ru(ii) and Ir(iii) phenanthroline-based photosensitisers bearing o-carborane: PDT agents with boron carriers for potential BNCT.
    Conway-Kenny R; Ferrer-Ugalde A; Careta O; Cui X; Zhao J; Nogués C; Núñez R; Cabrera-González J; Draper SM
    Biomater Sci; 2021 Aug; 9(16):5691-5702. PubMed ID: 34264257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of boron neutron capture therapy (BNCT) and the design and dosimetry of a high-intensity, 24 keV, neutron beam for BNCT research.
    Perks CA; Mill AJ; Constantine G; Harrison KG; Gibson JA
    Br J Radiol; 1988 Dec; 61(732):1115-26. PubMed ID: 3064858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modular triazine-based carborane-containing carboxylic acids - synthesis and characterisation of potential boron neutron capture therapy agents made of readily accessible building blocks.
    Kellert M; Worm DJ; Hoppenz P; Sárosi MB; Lönnecke P; Riedl B; Koebberling J; Beck-Sickinger AG; Hey-Hawkins E
    Dalton Trans; 2019 Aug; 48(29):10834-10844. PubMed ID: 31246208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,2-Diphenyl-
    Ha TJ; Im DK; Kim SM; Lee JD
    Molecules; 2023 Jun; 28(13):. PubMed ID: 37446604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphiphilic Polycarbonates from Carborane-Installed Cyclic Carbonates as Potential Agents for Boron Neutron Capture Therapy.
    Xiong H; Wei X; Zhou D; Qi Y; Xie Z; Chen X; Jing X; Huang Y
    Bioconjug Chem; 2016 Sep; 27(9):2214-23. PubMed ID: 27548011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodistribution of a carborane-containing porphyrin as a targeting agent for Boron Neutron Capture Therapy of oral cancer in the hamster cheek pouch.
    Kreimann EL; Miura M; Itoiz ME; Heber E; Garavaglia RN; Batistoni D; Rebagliati RJ; Roberti MJ; Micca PL; Coderre JA; Schwint AE
    Arch Oral Biol; 2003 Mar; 48(3):223-32. PubMed ID: 12648560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of cyclic RGD-boron cluster conjugates to develop tumor-selective boron carriers for boron neutron capture therapy.
    Kimura S; Masunaga S; Harada T; Kawamura Y; Ueda S; Okuda K; Nagasawa H
    Bioorg Med Chem; 2011 Mar; 19(5):1721-8. PubMed ID: 21315608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and characterization of boron fenbufen and its F-18 labeled homolog for boron neutron capture therapy of COX-2 overexpressed cholangiocarcinoma.
    Yeh CN; Chang CW; Chung YH; Tien SW; Chen YR; Chen TW; Huang YC; Wang HE; Chou YC; Chen MH; Chiang KC; Huang WS; Yu CS
    Eur J Pharm Sci; 2017 Sep; 107():217-229. PubMed ID: 28728977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.